Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
D. Garvanska, R. E. Alvarado, F. Mundt, E. Nilsson, J. Duel, F. Coscia, R. Lindqvist, K. Lokugamage, B. Johnson, J. A. Plante, D. R. Morris, M. N. Vu, L. Estes, A. McLeland, J. Walker, , J. Nilsson
This study identifies a novel interaction between SARS-CoV-2 NSP3 and FMRPs, showing that this interaction is critical for viral replication and disease progression.
bioRxiv · Sep 1, 2023 · PreprintMicrobiology
M. N. Vu, R. E. Alvarado, D. R. Morris, K. G. Lokugamage, Y. Zhou, A. L. Morgan, L. K. Estes, A. M. McLeland, C. Schindewolf, J. A. Plante, Y. P. Ahearn, W. M. Meyers, J. T. Murray, S. Weaver, D. H. Walker, , V. D. Menachery
This study identifies the N679K mutation in Omicron variants as reducing spike protein expression and attenuating SARS-CoV-2 infection, while showing a replication advantage in the upper airway.
bioRxiv · Apr 17, 2023Microbiology
A. Bouin, M. N. Vu, A. Al-Hakeem, G. P. Tran, J. H. C. Nguyen, B. L. Semler
This study investigates how 5-terminal deletions in enterovirus RNAs affect viral proteinase activity and replication, revealing cooperative interactions between full-length and deleted RNAs that influence viral persistence and pathogenesis.
bioRxiv · Sep 15, 2022Microbiology
B. A. Johnson, Y. Zhou, K. G. Lokugamage, M. N. Vu, N. E. Bopp, P. A. Crocquet-Valdes, B. Kalveram, C. Schindewolf, Y. Liu, D. Scharton, J. A. Plante, X. Xie, P. Aguilar, S. Weaver, P.-Y. Shi, , V. D. Menachery
This study shows that mutations in the SARS-CoV-2 nucleocapsid protein enhance viral replication and pathogenesis by increasing phosphorylation and resisting kinase inhibition.
PLOS Pathogens · Jun 21, 2022Peer-reviewedMicrobiology
M. N. Vu, K. Lokugamage, J. A. Plante, D. Scharton, B. A. Johnson, S. Sotcheff, D. Swetnam, C. Schindewolf, R. E. Alvarado, P. A. Crocquet-Valdes, K. Debbink, S. Weaver, D. H. Walker, A. L. Routh, K. S. Plante, V. D. Menachery
This study shows that deleting the QTQTN motif reduces SARS-CoV-2 replication and disease by affecting spike processing and glycosylation.
bioRxiv · Dec 15, 2021Microbiology
W. E. Matchett, V. Joag, J. M. Stolley, F. K. Shephard, C. F. Quarnstrom, C. K. Mickelson, S. Wijeyesinghe, A. G. Soerens, S. Becker, J. M. Thiede, E. Weyu, S. O'Flanagan, J. Walter, M. N. Vu, V. D. Menachery, , D. Masopust
This study shows that a nucleocapsid protein vaccine provides protective immunity against SARS-CoV-2, independent of spike protein targeting, in animal models.
bioRxiv · Apr 26, 2021Immunology
B. A. Johnson, X. Xie, B. Kalveram, K. G. Lokugamage, A. Muruato, J. Zou, X. Zhang, T. Juelich, J. K. Smith, L. Zhang, C. Schindewolf, M. N. Vu, A. Vanderheiden, J. A. Plante, K. S. Plante, , V. D. Menachery
This study shows that removing the furin cleavage site from SARS-CoV-2 increases replication in Vero cells but reduces replication in respiratory cells and pathogenesis in hamsters, while also decreasing neutralization susceptibility.
bioRxiv · Aug 26, 2020 · PreprintMicrobiology
Z. J. Sandler, M. N. Vu, V. D. Menachery, B. C. Mounce
This paper identifies novel antivirals, including valinomycin, active against La Crosse virus and other viruses by disrupting potassium ion homeostasis.
Antimicrobial Agents and Chemotherapy · May 21, 2020Peer-reviewedMicrobiology